These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4704163)

  • 21. Xeroderma pigmentosum. Clinical and laboratory investigation of its basic defect.
    Reed WB; Landing B; Sugarman G; Cleaver JE; Melnyk J
    JAMA; 1969 Mar; 207(11):2073-9. PubMed ID: 5818379
    [No Abstract]   [Full Text] [Related]  

  • 22. Xeroderma pigmentosum lesions related to ultraviolet transmittance by clothes.
    Bech-Thomsen N; Wulf HC; Ullman S
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 2):365-8. PubMed ID: 1999550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Photosensitization and protection from ultraviolet ray in xeroderma pigmentosum].
    Sato Y; Irimajiri T; Mifuji Y; Takeuchi I
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):728-31. PubMed ID: 304915
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sun and the skin].
    Vissian L; Lapeyre L
    Nouv Presse Med; 1974 Jul 20-27; 3(28):1760-9. PubMed ID: 4417004
    [No Abstract]   [Full Text] [Related]  

  • 25. Ultraviolet-B-induced apoptosis and cytokine release in xeroderma pigmentosum keratinocytes.
    Petit-Frère C; Capulas E; Lowe JE; Koulu L; Marttila RJ; Jaspers NG; Clingen PH; Green MH; Arlett CF
    J Invest Dermatol; 2000 Oct; 115(4):687-93. PubMed ID: 10998144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro photosensitivity of systemic lupus erythematosus skin fibroblasts.
    Zamansky GB; Minka DF; Deal CL; Hendricks K
    J Immunol; 1985 Mar; 134(3):1571-6. PubMed ID: 3968426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Xeroderma pigmentosum with normal excision-repair capacity and decreased U-V tolerance (author's transl)].
    Sandhofer M; Tuschl H; Kovac R; Altmann H
    Wien Klin Wochenschr; 1976 Apr; 88(9):296-9. PubMed ID: 973389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The therapeutic problem of cutaneous photosensitization. Considerations on a case of xeroderma pigmentosum].
    Tobia L
    Arch Sci Med (Torino); 1967 Mar; 123(3):140-7. PubMed ID: 6053189
    [No Abstract]   [Full Text] [Related]  

  • 29. Ultraviolet light-induced sister chromatid exchanges in xeroderma pigmentosum and in Cockayne's syndrome lymphocyte cell lines.
    Cheng WS; Tarone RE; Andrews AD; Whang-Peng JS; Robbins JH
    Cancer Res; 1978 Jun; 38(6):1601-9. PubMed ID: 647673
    [No Abstract]   [Full Text] [Related]  

  • 30. DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light.
    Baden HP; Parrington JM; Delhanty JD; Pathak MA
    Biochim Biophys Acta; 1972 Mar; 262(3):247-55. PubMed ID: 5038683
    [No Abstract]   [Full Text] [Related]  

  • 31. SKIN CHANGES DUE TO SOLAR RADIATION.
    WEBER G
    Aust J Dermatol; 1964 Jun; 7():148-52. PubMed ID: 14216055
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum.
    Grampurohit VU; Dinesh US; Rao R
    J Cancer Res Ther; 2011; 7(2):205-7. PubMed ID: 21768716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xeroderma pigmentosum clinical practice guidelines.
    Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
    J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Considerations and theories on the pathogenesis of xeroderma pigmentosum].
    Pezzi A
    Radiobiol Radioter Fis Med; 1968; 23(4):269-306. PubMed ID: 5707536
    [No Abstract]   [Full Text] [Related]  

  • 35. The corneal endothelium in xeroderma pigmentosum.
    Okubo K; Nakamura M; Nomura K; Kawakami J; Ichihashi M
    Ophthalmologica; 1987; 195(4):178-82. PubMed ID: 3431813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Xeroderma pigmentosum: development of photoformation of hydrogen peroxide and catalytic activity in skin cells; application to an early diagnosis and to a tentative treatment].
    Vuillaume M; Decroix Y; Calvayrac R; Vallot R; Best-Belpomme M
    C R Seances Acad Sci III; 1983; 296(18):845-50. PubMed ID: 6411296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Normal rate of DNA breakage in xeroderma pigmentosum complementation group E cells treated with 8-methoxypsoralen plus near-ultraviolet radiation.
    Bredberg A; Söderhäll S
    Biochim Biophys Acta; 1985 Mar; 824(3):268-71. PubMed ID: 3970936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pigmented xerodermoid. A defect of recombinational recovery following UV-injuries].
    Jung EG
    Arch Dermatol Forsch; 1971; 241(1):33-43. PubMed ID: 5560857
    [No Abstract]   [Full Text] [Related]  

  • 39. Xeroderma pigmentosum: the role of phototesting.
    Stone N; Reed J; Mahood J; Hardwick N; George S
    Br J Dermatol; 2000 Sep; 143(3):595-7. PubMed ID: 10971335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case report on xeroderma pigmentosum].
    Meffert H
    Padiatr Grenzgeb; 1974; 13(2-3):177-82. PubMed ID: 4408760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.